LOGO
  • About
  • Science
  • Patents
  • Academic Program
  • Blog
  • Industry News
  • e·Meditation
  • English
    • English
    • Русский
    • العربية
    • Deutsch
    • Español
    • Français
    • हिन्दी
    • 日本語
    • 한국어
    • Polski
    • Português
    • 简体中文
  1. Home
  2. blog

MRI-guided TMS reduces amygdala threat responses and improves PTSD symptoms

A randomized, blinded Emory trial found two weeks of MRI-guided low-frequency TMS reduced right amygdala threat responses and produced clinically meaningful PTSD symptom relief in 74% of treated participants, with benefits lasting at least six months.

21 Apr 2026

Pulsed taVNS elicits pupil dilation only with earlobe sham and short pulses, study finds

A Psychophysiology study (Apr 2026) finds pulsed taVNS produces pupil dilation in intermixed trials only with short (1.0 s) pulses and an earlobe sham; using a scapha sham or timing pulses to exhalation removed the effect, challenging a vagal-afferent mechanism.

21 Apr 2026

Trump signs order to speed review of psychedelics, including ibogaine

President Trump has signed an order to accelerate federal review of psychedelic drugs, including ibogaine, a substance backed by some veterans but linked to dangerous heart risks.

20 Apr 2026

brainjo raises €2M to advance VR adjunct for pediatric ADHD therapy

Regensburg startup brainjo raised €2 million in a seed round led by HTGF to fund clinical trials and regulatory work for a VR-based DiGA aimed at children with ADHD, developed with MEDICE Health Family and targeting approval in 2028.

20 Apr 2026

Tomsk Polytechnic University develops magnetoelectric nanoparticles for non‑invasive brain stimulation

Tomsk Polytechnic University researchers report sub‑30 nm magnetoelectric nanoparticles (manganese ferrite core, barium titanate shell) that, in lab tests, tripled neuronal calcium influx and activated 20% more cells; the team says particles are biocompatible at therapeutic concentrations and that in vivo studies are next.

20 Apr 2026

FDA clears Cala kIQ Plus wearable for Parkinson’s hand tremor

The FDA has cleared Cala Health’s Cala kIQ Plus, a wrist‑worn TAPS neurostimulation device for hand tremor in Parkinson’s and essential tremor; company data from 78 patients will be presented at AAN 2026.

19 Apr 2026
← 1 2 ... 10 11 12 13 14 15 16 ... 26 27 →

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

  • Announcements
  • Blog
  • Articles
  • Industry News
  • Science News

Archives

  • January 2022
  • January 2024
  • January 2025
  • January 2026
  • February 2023
  • February 2024
  • February 2026
  • March 2023
  • March 2024
  • March 2026
  • April 2025
  • April 2026
  • May 2020
  • May 2022
  • May 2026
  • June 2019
  • June 2022
  • June 2023
  • June 2025
  • June 2026
  • July 2022
  • July 2024
  • July 2025
  • July 2026
  • August 2022
  • August 2025
  • August 2026
  • September 2020
  • September 2024
  • September 2025
  • October 2019
  • October 2021
  • October 2022
  • October 2024
  • October 2025
  • November 2022
  • December 2021
  • December 2022

🍪 We use cookies

We use cookies to enhance your browsing experience and analyze our traffic. Privacy Policy

BrainPatch® and e·Meditation® is a registered trademarks of BrainPatch Ltd.

Follow Us

Site map

  • Home
  • About
  • News
  • Industry News
  • Companies
  • Science
  • Patents
  • Academic Program
  • e·Meditation Device

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • sales@brainpatch.ai
  •  

Contact Us

  • BrainPatch Limited,
    9 Hills Road, CB2 1GE, Cambridge, United Kingdom
    Company Number 11271285
    VAT GB310938419
  • BrainPatch Limited,
    Landscape House, Baldonnell Business Park, Baldonnell, Dublin, D223PK7, Ireland
    Company Number 678405

© 2026 All rights reserved. Created by: BrainPatch Ltd.

Privacy Policy